Format

Send to

Choose Destination
J Infect Dis. 2016 Dec 15;214(suppl 5):S441-S445.

Epidemiology of Chikungunya in the Americas.

Author information

1
Department of Pandemic and Epidemic Diseases, World Health Organization, Geneva, Switzerland.
2
Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
3
Department of International Health Regulations, Pan American Health Organization/World Health Organization, Washington D.C.

Abstract

Chikungunya virus (CHIKV) emerged in the Americas in late 2013 to cause substantial acute and chronic morbidity. About 1.1 million cases of chikungunya were reported within a year, including severe cases and deaths. The burden of chikungunya is unclear owing to inadequate disease surveillance and underdiagnosis. Virus evolution, globalization, and climate change may further CHIKV spread. No approved vaccine or antiviral therapeutics exist. Early detection and appropriate management could reduce the burden of severe atypical and chronic arthritic disease. Improved surveillance and risk assessment are needed to mitigate the impact of chikungunya.

KEYWORDS:

Americas; arbovirus; chikungunya; emerging disease; epidemiology

PMID:
27920170
PMCID:
PMC5137246
DOI:
10.1093/infdis/jiw390
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center